Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Niklas Sandler

The Power List 2020 – Small Molecules


Chief Technology Officer at Nanoform

Niklas Sandler has extensive experience in both industry and academia, particularly within the fields of pharmaceutical product development and material science. Alongside his role as chief technology officer at Nanoform, he is also a professor at Åbo Akademi University with over 100 published  papers in several pharmaceutical journals.

When asked if small molecules were still a big for pharma, he responded:

“Small molecules are still a crucial part of development pipelines and cover many therapeutic areas. New technologies, including nanotechnology, will boost the potential of these molecules to create future therapies. Also, old treatments will benefit from technologies that improve drug performance and provide life cycle extension opportunities for existing drugs.”


Part of the Power List 2020

The Power List 2020

Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.

Go to The Power List 2020

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register